A clinical trial to study effect of ERAS protocol in improving outcome in patients undergoing surgery for stomach cancer
Not Applicable
- Conditions
- Health Condition 1: C169- Malignant neoplasm of stomach, unspecifiedHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2022/03/041346
- Lead Sponsor
- SRIRAM V S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients admitted for elective gastrectomy procedure in the department of Surgery
Exclusion Criteria
Age < 18 years or > 75 years
ASA (American Society of Anesthesiologists) physical status more than III
Conditions that make cooperation with ERAS programme impossible (e.g. Mental disorder, paralysis)
Severe organ dysfunction (heart, brain, hepatic or renal)
Patients with diabetes who require High insulin therapy for uncontrolled diabetes/ Severe malnutrition
Distant metastases necessitating resection of other organs
Patients who cannot perform the prescribed respiratory prehabilitation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ength of hospitalization- from the day of admission to the day of discharge <br/ ><br> <br/ ><br>Length of postoperative hospital stay- measured from day of surgery to day of discharge. <br/ ><br>Timepoint: date of admission <br/ ><br>date of surgery <br/ ><br>date of discharge from hospital <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.Serum albumin and prealbumin <br/ ><br>2.C reactive protein <br/ ><br>3.Neutrophil count <br/ ><br>4.IL8, IL10 <br/ ><br>5.TNF-alpha <br/ ><br>6.Serum LDH <br/ ><br>7.IgG/IgMTimepoint: <br/ ><br>Measured at admission and postoperative day 3 and 7;Pulmonary complications (atelectasis, pleural effusion)Timepoint: every 24 hours in the postoperative period and at discharge <br/ ><br>